Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1235-1242

  Flak, Tod A ^a,b   Heiss, Linda N ^a   Engle, Jacquelyn T ^a   Goldman, William E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Milagen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; MURAMYL PEPTIDE;

ANIMAL CELL; ARTICLE; BORDETELLA PERTUSSIS; CELL CULTURE; CYTOKINE PRODUCTION; DNA SYNTHESIS INHIBITION; NONHUMAN; PATHOGENESIS; PERTUSSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ANIMALS; BORDETELLA PERTUSSIS; CELLS, CULTURED; CRICETINAE; CYTOTOXINS; DRUG SYNERGISM; ENDOTOXINS; EPITHELIUM; HUMANS; INTERLEUKIN-1; NITRIC OXIDE; PROTEIN KINASE C; TRACHEA;

EID: 0033963970     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1235-1242.2000     Document Type: Article

References (50)

1. Asano, T., and H. Hidaka. 1984. Vasodilatory action of HA1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide], a novel calcium antagonist with no effect on cardiac function. J. Pharmacol. Exp. Ther. 231:141-145.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1987. Current protocols in molecular biology. John Wiley & Sons, New York, N.Y.
3. Barratt, G. M., K. Raddassi, J.-F. Petit, and J.-P. Tenu. 1991. MDP and LPS act synergistically to induce arginine-dependent cytostatic activity in rat alveolar macrophages. Int. J. Immunopharmacol. 13:159-165.
4. Bruns, R. F., F. D. Miller, R. L. Merriman, J. J. Howbert, W. F. Heath, E. Kobayashi, I. Takahashi, T. Tamaoki, and H. Nakano. 1991. Inhibition of protein kinase C by calphostin C is light-dependent. Biochem. Biophys. Res. Commun. 176:288-293.
5. C'haby, R., and M. Caroff. 1988. Lipopolysaccharides of Bordetella pertussis endotoxin, p. 247-271. In A. C. Wardlaw and R. Parton (ed.), Pathogenesis and immunity in pertussis. John Wiley & Sons, Chichester, England.
6. Cookson, B. T., H.-L. Cho, L. A. Herwaldt, and W. E. Goldman. 1989. Biological activities and chemical composition of purified tracheal cytotoxin of Bordetella pertussis. Infect. Immun. 57:2223-2229.
7. Cookson, B. T., A. N. Tyler, and W. E. Goldman. 1989. Primary structure of the peptidoglycan-derived tracheal cytotoxin of Bordetella pertussis. Biochemistry 28:1744-1749.
8. Daemen, T., A. Veninga, J. Regts, and G. L. Scherphof. 1991. Maintenance of tumoricidal activity and susceptibility to reactivation of subpopulations of rat liver macrophages. J. Emmunother. 100:200-206.
9. Dinarello, C. A. 1991. Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases. Curr. Opin. Immunol. 3:941-948.
10. Dinarello, C. A., and J. M. Krueger. 1986. Induction of interleukin 1 by synthetic and naturally occurring muramyl peptides. Fed. Proc. 45:2545-2548.
11. Dokter, W. H. A., A. J. Dijkstra, S. B. Koopmans, A. B. Mulder, B. K. Stulp, W. Keck, M. R. Halie, and E. Vellenga. 1994. G(Anh)MTetra, a natural bacterial cell wall breakdown product, induces interleukin-1β and interleukin-6 expression in human monocytes. J. Biol. Chem. 269:4201-4206.
12. Flak, T. A., and W. E. Goldman. 1999. Signaling and cellular specificity of airway nitric oxide production in pertussis. Cell. Microbiol. 1:51-60.
13. Fuhlbrigge, R. C., S. M. Fine, E. Unanue, and D. D. Chaplin. 1988. Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA. Proc. Natl. Acad. Sci. USA 85:5649-5653.
14. Gaston, B., J. M. Drazen, J. Loscalzo, and J. S. Stamler. 1994. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 149:538-551.
15. Gold, M. R., C. L. Miller, and R. I. Mishell. 1985. Soluble non-cross-linked peptidoglycan polymers stimulate monocyte-macrophage inflammatory functions. Infect. Immun. 49:731-741.
16. Goldman, W. E., and J. B. Baseman. 1980. Selective isolation and culture of a proliferating epithelial cell population from the hamster trachea. In Vitro 16:313-319.
17. Goldman, W. E., D. G. Klapper, and J. B. Baseman. 1982. Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells. Infect. Immun. 36:782-794.
18. Goodell, E. W., and U. Schwarz. 1985. Release of cell wall peptides into culture medium by exponentially growing Escherichia coli. J. Bacteriol. 162: 391-397.
19. 15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
20. Heiss, L. N. 1993. Ph.D. dissertation. Washington University, St. Louis, Mo.
21. Heiss, L. N., J. R. Lancaster, Jr., J. A. Corbett, and W. E. Goldman. 1994. Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proc. Natl. Acad. Sci. USA 91:267-270.
22. Heiss, L. N., S. A. Moser, E. R. Unanue, and W. E. Goldman. 1993. Interleukin-1 is linked to the respiratory epithelial cytopathology of pertussis. Infect. Immun. 61:3123-3128.
23. Hidaka, H., M. Inagaki, S. Kawamoto, and Y. Sasaki. 1984. Isoquinoline-sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23:5036-5041.
24. Hill, J. R., J. A. Corbett, A. C. Baldwin, and M. L. McDaniel. 1996. Nitric oxide production by the rat insulinoma cell line, RINm5F, is specific for IL-1: a spectrophotometric IL-1 bioassay. Anal. Biochem. 236:14-19.
25. Höltje, J. V., D. Mirelman, N. Sharon, and U. Schwarz. 1975. Novel type of murein transglycosylase in Escherichia coli. J. Bacteriol. 124:1067-1076.
26. Inagaki, M., S. Kawamoto, H. Itoh, M. Saitoh, M. Hagiwara, J. Takahashi, and H. Hidaka. 1986. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors. Mol. Pharmacol. 29:577-581.
27. 2+/calmodulin-dependent cyclic nucleotide phosphodiesterase. J. Biochem. 96:1721-1726.
28. Jarrous, N., and R. Kaempfer. 1994. Induction of human interleukin-1 gene expression by retinoic acid and its regulation at processing of precursor transcripts. J. Biol. Chem. 269:23141-23149.
29. Johannsen, L., F. Obal, Jr., L. Kapas, V. Kovalzon, and J. M. Krueger. 1994. Somnogenic activity of muramyl peptide-derived immune adjuvants. Int. J. Immunopharmacol. 16:109-116.
30. Kobayashi, E., H. Nakano, M. Morimoto, and T. Tamaoki. 1989. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:548-553.
31. Krueger, J. M., R. S. Rosenthal, S. A. Martin, J. Walter, D. Davenne, S. Shoham, S. L. Kubillus, and K. Biemann. 1987. Bacterial peptidoglycans as modulators of sleep. I. Anhydro forms of muramyl peptides enhance somnogenic potency. Brain Res. 403:249-257.
32. Le Contel, C., N. Temime, D. J. Charron, and M. A. Parant. 1993. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide. J. Immunol. 10: 4541-4549.
33. Lee, S., W., V. B. Morhenn, M. Ilnicka, E. M. Eugui, and A. C. Allison. 1991. Autocrine stimulation of interleukin-1 alpha and transforming growth factor alpha production in human keratinocytes and its antagonism by glucocorticoids. J. Investig. Dermatol. 97:106-110.
34. Lee, W. Y., A. P. Butler, M. F. Locniskar, and S. M. Fischer. 1994. Signal transduction pathway(s) involved in phorbol ester and autocrine induction of interleukin-1α mRNA in murine keratinocytes. J. Biol. Chem. 269:17971-17980.
35. Luker, K. E., J. L. Collier, E. W. Kolodziej, G. R. Marshall, and W. E. Goldman. 1993. Bordetella pertussis tracheal cytotoxin and other muramyl peptides: distinct structure-activity relationships for respiratory epithelial cytopathology. Proc. Natl. Acad. Sci. USA 90:2365-2369.
36. Luker, K. E., A. N. Tyler, G. R. Marshall, and W. E. Goldman. 1995. Tracheal cytotoxin structural requirements for respiratory epithelial damage in pertussis. Mol. Microbiol. 16:733-743.
37. Nakajima, K., T. Kusafuka, T. Takeda, Y. Fujitani, K. Nakae, and T. Hirano. 1993. Identification of a novel interleukin-6 response element containing an Ets-binding site and a CRE-like site in the junB promoter. Mol. Cell. Biol. 13:3027-3041.
38. Nakajima, K., and R. Wall. 1991. Interleukin-6 signals activating junB and TISI1 gene transcription in a B-cell hybridoma. Mol. Cell. Biol. 11:1409-1418.
39. Nishizuka, Y. 1986. Studies and perspectives of protein kinase C. Science 233:305-312.
40. Parant, M., and L. Chedid. 1990. Various aspects of synergism between endotoxin and MDPs. Adv. Exp. Med. Biol. 256:537-547.
41. Parant, M., F. Parant, M. A. Vinit, C. Jupin, Y. Noso, and L. Chedid. 1990. Priming effect of muramyl peptides for induction by lipopolysaccharide of tumor necrosis factor production in mice. J. Leukoc. Biol. 47:164-169.
42. Park, J. T. 1993. Turnover and recycling of the murein sacculus in oligopeptide permease-negative strains of Escherichia coli: indirect evidence for an alternative permease system and for a monolayered sacculus. J. Bacteriol. 175:7-11.
43. Pugin, J., I. D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishyima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509-516.
44. Roufogalis, B. D., A. M. Minocherhomjee, and A. Al-Jobore. 1983. Pharmacological antagonism of calmodulin. Can. J. Biochem. Physiol. 41:927-933.
45. Shi, F., I. D. Kurzman, and E. G. MacEwen. 1995. In vitro and in vivo production of interleukin-6 induced by muramyl peptides and lipopolysaccharide in normal dogs. Cancer Biother. 10:317-325.
46. Vacheron, F., M. Guenounou, and C. Nauciel. 1983. Induction of interleukin 1 secretion by adjuvant-active peptidoglycans. Infect. Immun. 42:1049-1054.
47. Vermeulen, M. W., and G. R. Gray. 1984. Processing of Bacillus subtilis peptidoglycan by a mouse macrophage cell line. Infect. Immun. 46:476-483.
48. Warner, S. J., and P. Libby. 1989. Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J. Immunol. 142:100-109.
49. Weidemann, B., H. Brade, E. T. Rietschel, R. Dziarski, V. Bazil, S. Kusumoto, H.-D. Flad, and A. J. Ulmer. 1994. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect. Immun. 62:4709-4715.
50. Yin, T., and Y. C. Yang. 1994. Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells. J. Biol. Chem. 269:3731-3738.